Schizophrenia and Mood Disorders: The New Drug Therapies in Clinical Practice by Peter (ed) Buckley
This authoritative reference draws upon, and combines the similarities and differences between European and American practices in the diagnosis and treatment of mood disorders and schizophrenia to provide an international approach to drug therapies. By including the most up-to-date knowledge, best practices, and clinical pearls from each continent, the editors and the 48 international expert contributors have ensured that this is a critical resource for clinicians prescribing for their patients.
The first two sections address the use of a variety of antipsychotic medications for the treatment of schizophrenia, and the clinical use of antidepressant medications and mood stabilizers for depression and mania. The authors discuss their experiences of treatment using some of the most recently available drugs and others which are currently under development. The key issues of concern to the clinician, and broader topics of clinical psychopharmacology, are addressed in the final section which covers underlying principles and offers practical advice.
The first two sections address the use of a variety of antipsychotic medications for the treatment of schizophrenia, and the clinical use of antidepressant medications and mood stabilizers for depression and mania. The authors discuss their experiences of treatment using some of the most recently available drugs and others which are currently under development. The key issues of concern to the clinician, and broader topics of clinical psychopharmacology, are addressed in the final section which covers underlying principles and offers practical advice.